Jiangsu Provincial Key Laboratory of Molecular Medicine
Proposed by Nanjing University Medical School in 2007 according to Construction Plan of Jiangsu Science and Technology Infrastructure, Jiangsu Key Laboratory of Molecular Medicine was founded in 2011. It now owns more than 30 PI laboratories and has achieved rich fruits by equipment of high level. The lab comprises 3 research platforms related to the Biomedical Science which including Translational Medicine Center of Nanjing University Medical School, Gulou Hospital Central Laboratory of Nanjing University Medical School, and the Gene transformation platform of the Nanjing University Model Animal Research Institute. Three main research areas were established since the lab’s foundation.
Gene transformation and modal animalsSupported by Nanjing University Model Animal Research Institute, a key laboratory, the lab established the gene transformational animal models of mice, rats and large animals with gene transformation technology as its key point to breakthrough. Besides creating a database of Chinese ill animals, the lab independently transformed the genes of more than 100 animals and introduced in more than 1000 for exotic animal models. An international breakthrough was made in the transformation of new technology of the 3rd gene generation.
Molecular Diagnostics and Cell Therapy The lab conducts research on molecular mechanism of diseases, clinical diagnosis, identical diagnosis, treatment supervision and the application of clinical cell therapy. It has reach the international level in tailored medication for tumor, treatment of refractory autoimmune diseases and the clinical application of novel artificial liver. The lab has received several national scientific advancement awards (second class), national natural science award (second class) and scientific advancement awards (first award) by the Ministry of Education.
Disease Mechanism and Basic Medicine Research is conducted on the application of pathogenic microbes, molecular mechanisms of metabolism and immune diseases, medical genetics and the technology of new materials and new optical technology. The lab has made several breakthrough by publishing a number of theses about high impact factors which has pushed the researching level of such diseases to a new height.
